Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer

BJU International

Volumn 111, Issue 5, 2013, Pages 723-730

  Lughezzani, Giovanni ^a   Gallina, Andrea ^a   Larcher, Alessandro ^a   Briganti, Alberto ^a   Capitanio, Umberto ^a   Suardi, Nazareno ^a   Lista, Giuliana ^a   Abrate, Alberto ^a   Sangalli, Mattia Nicola ^a   Buffi, Nicolòmaria ^a   Cestari, Andrea ^a   Guazzoni, Giorgio ^a   Rigatti, Patrizio ^a   Montorsi, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

cancer specific survival; high Gleason score; prostate cancer; radical prostatectomy

Indexed keywords

HORMONE ANALOG; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLINICAL EFFECTIVENESS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PELVIS LYMPH NODE DISSECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; ITALY; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84876292494     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11114.x     Document Type: Article

References (20)

1. Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005; 23: 7005-7012
2. Kattan MW, Wheeler TM, Scardino PT,. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999; 17: 1499-1507
3. Cooperberg MR, Moul JW, Carroll PR,. The changing face of prostate cancer. J Clin Oncol 2005; 23: 8146-8151
4. Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR,. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE). J Urol 2005; 173: 1557-1561
5. Partin AW, Lee BR, Carmichael M, Walsh PC, Epstein JI,. Radical prostatectomy for high grade disease: a reevaluation 1994. J Urol 1994; 151: 1583-1586
6. Oefelein MG, Smith ND, Grayhack JT, Schaeffer AJ, McVary KT., Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J Urol 1997; 158: 1460-1465
7. Tefilli MV, Gheiler EL, Tiguert R, et al. Role of radical prostatectomy in patients with prostate cancer of high Gleason score. Prostate 1999; 39: 60-66
8. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H,. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol 2002; 167: 117-122
9. Pierorazio PM, Guzzo TJ, Han M, et al. Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. Urology 2010; 76: 715-721
10. McNeal JE, Redwine EA, Freiha FS, Stamey TA., Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988; 12: 897-906
11. Gleason DF, Mellinger GT,. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58-64
12. Dvorak T, Ming-Hui C, Renshaw A, Loffredo M, Richie J, D'Amico A., Maximal tumor diameter and the risk of PSA failre in men with specimen-confined prostate cancer. Urology 2005; 66: 1024-1028
13. Bill-Axelson A, Holmberg L, Filen F, et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008; 100: 1144-1154
14. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977-1984
15. Gallina A, Chun FK, Suardi N, et al. Comparison of stage migration patterns between Europe and the USA: an analysis of 11350 men treated with radical prostatectomy for prostate cancer. BJU Int 2008; 101: 1513-1518
16. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM,. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994; 152: 1850-1857
17. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC,. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28: 555-565
18. Bahler CD, Foster RS, Bihrle R, et al. Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate cancer. BJU Int 2010: 105: 1372-1376
19. Kamat AM, Babaian K, Cheung MR, et al. Identification of factors predicating response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy. J Urol 2003; 170: 1860-1863
20. Macdonald OK, Lee RJ, Snow G, et al. Prostate-specific antigen control with low dose adjuvent radiotherapy for high-risk prostate cancer. Urology 2007; 69: 295-299